Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
erastin
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(5)
News
Trials
Company:
Columbia University, Dana-Farber Cancer Institute, Prolexys, Whitehead Institute for Biomedical Research
Drug class:
Ferroptosis inducer
Related drugs:
‹
RSL3 (3)
ML210 (2)
HSB-1216 (0)
RSL3 (3)
ML210 (2)
HSB-1216 (0)
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
GSK3B overexpression
Breast Cancer
GSK3B overexpression
Breast Cancer
erastin
Sensitive: D – Preclinical
erastin
Sensitive
:
D
erastin
Sensitive: D – Preclinical
erastin
Sensitive
:
D
GPX4 expression
Prostate Cancer
GPX4 expression
Prostate Cancer
erastin
Sensitive: D – Preclinical
erastin
Sensitive
:
D
erastin
Sensitive: D – Preclinical
erastin
Sensitive
:
D
SLC3A2 expression
Prostate Cancer
SLC3A2 expression
Prostate Cancer
erastin
Sensitive: D – Preclinical
erastin
Sensitive
:
D
erastin
Sensitive: D – Preclinical
erastin
Sensitive
:
D
SLC7A11 expression
Prostate Cancer
SLC7A11 expression
Prostate Cancer
erastin
Sensitive: D – Preclinical
erastin
Sensitive
:
D
erastin
Sensitive: D – Preclinical
erastin
Sensitive
:
D
ACSM3 overexpression
Prostate Cancer
ACSM3 overexpression
Prostate Cancer
erastin
Resistant: D – Preclinical
erastin
Resistant
:
D
erastin
Resistant: D – Preclinical
erastin
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login